Advanced Alzheimer's Disease Patients Show Safe, Significant, and Persistent Benefit in 6-Month Bryostatin Trial. Alkon DL, Sun M-K, Tuchman AJ, Thompson RE J Alzheimers Dis. 2023; 96(2):759-766. PMID: 37742657. Abstract Comment Bookmark Recommend Follow Comment | Bookmark | Recommend | Follow